AstraZeneca-Ionis drug fails to meet main goal in late-stage heart disease trial
AstraZeneca said on Thursday that its drug Wainua, made in partnership with Ionis, failed to meet the main goal of reducing cardiovascular deaths and recurring heart problems in a late-stage trial.
(Reporting by Raechel Thankam Job in Bengaluru; Editing by Janane Venkatraman)
Copyright Reuters or USA Today Network via Reuters Connect
This story was originally published July 8, 2026 at 11:25 PM.